Your session is about to expire
← Back to Search
Behavioral Intervention
Sexual Assault Resistance Training for Adolescent Girls (SARE-A Trial)
N/A
Recruiting
Led By Charlene Y Senn, PhD
Research Sponsored by University of Windsor
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-week post intervention, 6-months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a program can reduce sexual violence perpetrated against teen girls in high school. If successful, it could reduce rape attempts & completed rape by 50%.
Who is the study for?
This trial is for self-identified girls aged 14 to 18 who haven't graduated high school, can understand and communicate in English, and are able to attend the program during the data collection period. There are no specific exclusion criteria mentioned.
What is being tested?
The study tests an adapted version of the Enhanced Assess, Acknowledge, Act (EAAA) sexual assault resistance education program for younger girls. It compares immediate participation with a delayed start at six months to see if it reduces sexual violence.
What are the potential side effects?
Since this is an educational intervention rather than a medical treatment, traditional side effects aren't expected. However, participants may experience emotional or psychological responses due to discussing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six months after randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months after randomization
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Completed Rape
Secondary study objectives
Attempted Rape
Other study objectives
Detection of Risk Cues
Experience of Embodiment
Knowledge/Willingness to use Effective Self-Defense Strategies
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: A-EAAA (Adolescent Enhanced Assess, Acknowledge, Act) immediatelyExperimental Treatment1 Intervention
Adolescent adaptation of EAAA sexual assault resistance education (4, 3-hr sessions) begun immediately after baseline randomization
Group II: Waitlist ControlActive Control1 Intervention
Usual care 30-min session (brief presentation on consent/sexual assault; access to local resource pamphlets) immediately after baseline randomization; A-EAAA (4, 3-hr sessions) at 6-months post-randomization
Find a Location
Who is running the clinical trial?
Public Health Agency of Canada (PHAC)OTHER_GOV
49 Previous Clinical Trials
98,447 Total Patients Enrolled
University of WindsorLead Sponsor
13 Previous Clinical Trials
6,548 Total Patients Enrolled
2 Trials studying Sexual Assault
2,836 Patients Enrolled for Sexual Assault
Charlene Y Senn, PhDPrincipal InvestigatorUniversity of Windsor
2 Previous Clinical Trials
2,836 Total Patients Enrolled
2 Trials studying Sexual Assault
2,836 Patients Enrolled for Sexual Assault
Sara E Crann, PhDPrincipal InvestigatorUniversity of Windsor (on leave Feb 2023-Jan 2024)
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.I am a girl aged between 14 and 18.
Research Study Groups:
This trial has the following groups:- Group 1: A-EAAA (Adolescent Enhanced Assess, Acknowledge, Act) immediately
- Group 2: Waitlist Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.